$117 Thousand is the total value of DOHENY ASSET MANAGEMENT /CA's 72 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | ROCKHOPPER EXPL PL ORDF | $0 | – | -25,000 | -100.0% | -0.00% | – | |
| ATIP | Exit | ATI PHYSICAL THERAPY INC | $0 | – | -38,150 | -100.0% | -0.01% | – |
| WHD | Exit | CACTUS INC CLASS A | $0 | – | -16,825 | -100.0% | -0.62% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Cordhaven Capital #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE INC COM | 41 | Q3 2023 | 14.9% |
| MICROCHIP TECHNOLOGY INC | 41 | Q3 2023 | 4.2% |
| JOHNSON & JOHNSON COM | 41 | Q3 2023 | 2.9% |
| LXP INDUSTRIAL TRUST REIT | 41 | Q3 2023 | 3.7% |
| CHECK PT SOFTWARE F | 41 | Q3 2023 | 3.8% |
| GILEAD SCIENCES INC. | 41 | Q3 2023 | 4.2% |
| MERCK & CO INC NEW | 41 | Q3 2023 | 2.6% |
| STARBUCKS CORP COM | 41 | Q3 2023 | 2.6% |
| HALOZYME THERAPEUTICS INC | 41 | Q3 2023 | 3.6% |
| CHEVRON CORPORATION | 41 | Q3 2023 | 2.0% |
View DOHENY ASSET MANAGEMENT /CA's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-08 |
| 13F-HR | 2024-02-06 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-10-22 |
View DOHENY ASSET MANAGEMENT /CA's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.